ArticleEuropean heart journal. Case reports2025
Electrosurgical-laceration and stabilization of two PASCAL devices using artificial intelligence-based procedural planning: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.JACC. Cardiovascular interventions · 2026Guideline
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mitral transcatheter edge-to-edge repair (M-TEER) has been established as a treatment for severe mitral regurgitation (MR). However, recurrent MR may occur after successful primary M-TEER. Repeat M-TEER procedures are challenging or even anatomically unfeasible. Therefore, novel techniques like electrosurgical laceration from the anterior leaflet and stabilization (ELASTA) of M-TEER devices are important. Case summary: An 85-year-old male presented with recurrent cardiac decompensations and relevant dyspnoea [New York Heart Association (NYHA) functional Class III-IV] caused by severe MR and heart failure. Four years earlier, the patient underwent M-TEER with two PASCAL devices due to severe primary MR. Echocardiography revealed two significant regurgitation jets, representing severe recurrent MR. Repeated M-TEER was prohibitive due to an elevated mean transvalvular gradient (6.2 mmHg) and surgery was deemed unfeasible. A computed tomography (CT) was performed using software based on artificial intelligence (AI) for automatic analysis of the mitral valve anatomy. The heart team then decided to perform an ELASTA of the two PASCAL devices with subsequent transapical transcatheter mitral valve implantation (TMVI). The procedure was performed without complications and achieved optimal haemodynamic outcomes. Discussion: The frequency of M-TEER procedures will rise, leading to a corresponding increase of recurrent MR requiring treatment. However, additional edge-to-edge repair is often not feasible due to space limitations, elevated inflow gradients, or progressive calcification of valve leaflets. Emerging electrosurgical techniques, such as ELASTA, combined with subsequent TMVI, offer promising solutions for recurrent MR. Computed tomography imaging plays a critical role in procedural planning, and AI-driven programs have the potential to significantly improve and optimize these analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.